Skip to main content

Table 1 Clinical parameters between smokers and non-smokers at baseline (before cessation of smoking)

From: Long term effects of smoking cessation in hospitalized schizophrenia patients

 

Smokers

Non-smokers

P value

Number

38

32

 

Sex

7/31

11/21

 

Age (years)

57.9 ± 12.5

54.3 ± 13.6

0.241

Duration of illness

33.2 ± 14.5

32.7 ± 13.5

0.876

ln total1

4.5 ± 1.2

3.9 ± 1.2

0.071

ln LF1

3.8 ± 1.3

3.2 ± 1.4

0.163

ln HF1

3.8 ± 1.2

3.1 ± 1.3

0.016*

BMI (kg/m2)

22.7 ± 4.0

21.7 ± 4.0

0.276

ALB (g/dL)

4.0 ± 0.3

4.0 ± 0.4

0.204

BS (mg/dL)

89.7 ± 17.4

87.5 ± 15.5

0.655

LDL-C (mg/dL)

119.0 ± 33.2

108.4 ± 29.6

0.163

TC (mg/dL)

200.4 ± 42.2

183.9 ± 32.0

0.065

TG (mg/dL)

118.9 ± 91.1

86.0 ± 43.2

0.073

HDL-C (mg/dL)

60.4 ± 16.6

55.9 ± 13.2

0.222

CPZeq*2 (mg)

1229 ± 750

1162 ± 792

0.717

BPDeq*2 (mg)

2.9 ± 1.9

1.6 ± 1.6

0.003*

DZPeq*2 (mg)

10.1 ± 6.9

9.3 ± 7.4

0.653

GAF score

28.9 ± 3.1

29.2 ± 2.2

0.682

  1. Data are presented as means ± standard deviation
  2. *Significant difference (p < 0.05)
  3. 1Logarithmic conversion was performed
  4. 2Daily dose of antipsychotic was converted to the approximate respective equivalent dose
  5. LF Low Frequency, HF High frequency, BMI Body mass index, ALB Serum albumin, BS Blood sugar, LDL-C Low-density lipoprotein cholesterol, TC Total cholesterol, TG Triglycerides, HDL-C High-density lipoprotein cholesterol, CPZeq Equivalent conversions of chlorpromazine, BDPeq Equivalent conversions of biperiden, DZP Equivalent conversions of diazepam, GAF Global Assessment of Functioning